By Nancy A. Melville; Victoria Stern
Source Medscape
While major guidelines support mammography for routine breast cancer screening in average-risk women, the decision to offer additional screening and which supplemental tool to use can become more complicated.
Certain supplemental screening options improve cancer detection but may increase the risk for false-positive findings and unnecessary biopsies, while others may offer limited additional cancer detection benefits.
Ultimately, “not all supplemental screening tests are created equal,” Bethany L. Niell, MD, PhD, a diagnostic radiologist and section chief of breast imaging at Moffitt Cancer Center, Tampa, Florida, told Medscape Medical News. At the recent National Comprehensive Cancer Network (NCCN) annual conference, Niell explored differences among some of the most common supplemental modalities — including digital breast tomosynthesis, ultrasound, and MRI — and aimed to help clarify options for different patients.
Read more https://medscape.com/viewarticle/higher-risk-breast-cancer-screening-which-test-use-2024a100099v